Director, Patient Engagement & Advocacy (State & Grassroots)
Neurocrine Biosciences
- Location
- US CA Home Office
- Employment
- Full Time
- Work model
- On-Site
- Level
- Staff
- H-1B history
- 1 approvals (FY2023)
- Posted
- Sep 21, 2026
About this role
Who We Are
Neurocrine Biosciences is a leading biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering, developing and commercializing life-changing treatments for patients with under-addressed neurological, psychiatric, endocrine and immunological disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader-Willi syndrome, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit neurocrine.com , and follow the company on LinkedIn , X , Facebook and YouTube . ( *in collaboration with AbbVie ) At Neurocrine, strong leadership drives both business results and team success. We look for leaders who think strategically, anticipate what’s ahead and set clear direction, while building and empowering high-performing teams. Successful leaders foster an environment where people are motivated to do their best work and deliver meaningful, measurable impact through sound decision-making and accountability.

 About the Role: Preferred work location - San Diego, CA or Washington DC. Open to remote The Director, State & Grassroots Patient Engagement & Advocacy (PEA) provides strategic leadership for field-based patient engagement & advocacy across assigned Endocrinology therapeutic programs and brands. Reporting to the Senior Director, Endocrinology PEA, this role translates national patient engagement & advocacy strategy into coordinated state, regional, and local engagement plans that strengthen relationships with patient advocacy organizations and community stakeholders while ensuring patient and caregiver perspectives inform business decisions. Working collaboratively across Corporate Affairs and the broader organization, the Director serves as Neurocrine's strategic lead to the patient community at the state and local level for assigned therapeutic programs. This role develops long-term partnerships with state and grassroots patient advocacy organizations, provides strategic leadership for field-based patient engagement across internal functions, strengthens and protects Neurocrine's reputation within local patient communities, generates actionable community insights, and ensures local perspectives meaningfully inform enterprise strategy and decision making. _ Your Contributions (include, but are not limited to): Strategic Leadership Lead the development and execution of state and grassroots patient engagement strategies for assigned Endocrinology therapeutic programs and brands, ensuring alignment with enterprise priorities while addressing regional and local community needs Translate national patient engagement strategy into coordinated field engagement plans that support business objectives while meeting the unique needs of local patient communities Identify emerging community needs, trends, and opportunities, translating local insights into actionable recommendations that inform enterprise strategy and business decisions State & Grassroots Partnership Leadership Develop and steward long-term strategic relationships with state, regional, and grassroots patient advocacy organizations and other community stakeholders, serving as a trusted partner while advancing shared objectives Strengthen and protect Neurocrine's reputation and credibility within local patient communities by fostering transparent, collaborative, and mutually beneficial partnerships that reflect the